We are live on ! Find out more
CBAY

Cymabay Therapeutics
CBAY

Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

17 hedge funds and large institutions have $33.9M invested in Cymabay Therapeutics in 2014 Q3 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+17
Holders Change %
–
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LOAMU
Lombard Odier Asset Management (USA)
New York
+$7.68M
2
Jennison Associates
Jennison Associates
New York
+$6.15M
3
SAM
Sectoral Asset Management
Quebec, Canada
+$4.35M
4
DM
Deerfield Management
New York
+$3.15M
5
SFM
Sphera Funds Management
Israel
+$3.01M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LOAMU
1
Lombard Odier Asset Management (USA)
New York
$8.55M +$7.68M +1,250,000 New
Jennison Associates
2
Jennison Associates
New York
$6.84M +$6.15M +1,000,000 New
SAM
3
Sectoral Asset Management
Quebec, Canada
$4.85M +$4.35M +708,585 New
DM
4
Deerfield Management
New York
$3.51M +$3.15M +513,206 New
SFM
5
Sphera Funds Management
Israel
$3.35M +$3.01M +490,355 New
RSCM
6
Rock Springs Capital Management
Maryland
$2.05M +$1.84M +300,000 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.93M +$1.74M +282,447 New
AllianceBernstein
8
AllianceBernstein
Tennessee
$1.61M +$1.44M +234,974 New
IHM
9
Iguana Healthcare Management
New York
$855K +$768K +125,000 New
EEG
10
E.E. Geduld
$171K +$154K +25,000 New
ACI
11
Alpha Cubed Investments
California
$137K +$123K +20,000 New
Barclays
12
Barclays
United Kingdom
$14K +$14.7K +2,400 New
ClearBridge Investments
13
ClearBridge Investments
New York
$12K +$10.8K +1,760 New
CWAM
14
Columbia Wanger Asset Management
Illinois
$2K +$1.4K +228 New
SM
15
Sabby Management
Florida
$1.71K +$1.54M +249,900 New
Morgan Stanley
16
Morgan Stanley
New York
– +$154 +25 New
Citigroup
17
Citigroup
New York
– +$264 +43 New

CBAY Hedge Fund Activity: Q3 2014 in Review

17 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Cymabay Therapeutics (CBAY) for Q3 2014, worth a combined $33.9M.

Buyers outnumbered sellers: 17 funds opened new CBAY positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Lombard Odier Asset Management (USA), opening a new position worth an estimated $7.68M.

  • 17 institutional investors held Cymabay Therapeutics (CBAY) as of Q3 2014, up from 0 in Q2 2014.
  • Funds reported $33.9M of Cymabay Therapeutics stock for Q3 2014.
  • 17 funds opened new Cymabay Therapeutics positions in Q3 2014 and 0 closed out, a net change of +17 holders.
  • The largest Cymabay Therapeutics buyer in Q3 2014 was Lombard Odier Asset Management (USA), an estimated $7.68M added.

Based on aggregated 13F filings for Q3 2014.